CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ½ÅÇö¼ö
  • ¹æ»ç¼±Á¾¾çÇаú °úÀå
    ÀûÁ¤Áø·á°ü¸®ºÎÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : À¯¹æ¾Ï/»óºÎ¼ÒÈ­±â¾Ï/³úÁ¾¾ç(novalis)/ºñ´¢±â¾Ï
  • Á÷ À§: ±³¼ö(¹æ»ç¼±Á¾¾çÇаúÀå,ÀûÁ¤Áø·á°ü¸®ºÎÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
26 (±¹³»)KCI Risk Factors for Distant Metastasis as a Primary Site of Treatment Failure in Early-Stage Breast Cancer
25 (±¹¿Ü)SCI Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study
24 (±¹³»)SCOPUS Esophageal tolerance to high dose stereotactic radiosurgery.
23 (±¹¿Ü)SCI The Role of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy in Clinical Stage II-III Breast Cancer Patients With pN0: A Multicenter, Retrospective Study (KROG 12-05)
22 (±¹¿Ü)SCI Stage IE/IIE extranodal NK/T-cell lymphoma arising in the nasal cavity: Analysis of CT findings and their prognostic value.
21 (±¹³»)SCIE Outcomes of Gleason score ¡Â 8 among high risk prostate cancer treated with 125I low dose rate brachytherapy based multimodal therapy
20 (±¹¿Ü)SCI Placenta-Derived Mesenchymal Stem Cells Have an Immunomodulatory Effect That Can Control Acute Graft-Versus-Host Disease in Mice
19 (±¹³»)SCOPUS Treatment Outcome in Patients with Triple Negative Early Stage Breast Cancers Compared with other Molecular Subtypes.
18 (±¹³»)SCI Optimum Conditions of the Plasma Density for the Generation of theMaximum Bunch Charge in a Laser Wakefield Accelerator
17 (±¹¿Ü)SCI Treatment Results of Post-operative Radiotherapy in Patients with Salivary Duct Carcinoma of the Major Salivary Glands.
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729